Actinin-4 protein overexpression as a predictive biomarker in adjuvant chemotherapy for resected lung adenocarcinoma.
Shiraishi H, Fujiwara Y, Kakuya T, Tsuta K, Motoi N, Miura N, Watabe Y, Watanabe SI, Noro R, Nagashima K, Huang W, Yamada T, Asamura H, Ohe Y, Honda K.
Shiraishi H, et al. Among authors: motoi n.
Biomark Med. 2017 Sep;11(9):721-731. doi: 10.2217/bmm-2017-0150. Epub 2017 Jun 29.
Biomark Med. 2017.
PMID: 28658966
Free article.